Paushak Ltd
PAUSHAKLTD
Company Profile
Business description
Paushak Ltd manufactures and develops phosgene-based specialty chemicals and intermediates. The company operates in only one segment, Speciality chemicals. It produces Isocyanates such as 2-Phenyl Ethyl isocyanate, Cyclohexyl isocyanate; Chloroformates which include Benzyl chloroformate, 2- Ethylhexyl chloroformate, Isobutyl chloroformate and Carboamoyl Chlorides such as Diethylcarbamoyl Chloride, and N-Ethyl-N-Methylcarbamoyl Chloride and others. Geographically, the company has a business presence in India and outside India, from which a majority of its revenue is derived within India.
Contact
Alembic Road
VadodaraGJ390003
INDT: +91 2656637000
Sector
Basic Materials
Stock type
Cyclical
Industry
Specialty Chemicals
Fiscal Year End
31 March 2027
Employees
380
Stocks News & Analysis
stocks
Investors punish this ASX player after acquisition
We think the floundering stock price is not reflective of underlying asset value.
stocks
Revenue growth on track for undervalued ASX healthcare stock
Near-term cost growth does not change our long-term view.
stocks
Sales shine but broader macro outlook darkens for this ASX share
US stores are struggling, but our investment thesis hinges on the Australian rollout.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,155.80 | 34.00 | 0.37% |
| CAC 40 | 8,259.60 | 13.81 | 0.17% |
| DAX 40 | 23,803.95 | 3.04 | -0.01% |
| Dow JONES (US) | 47,916.57 | 269.23 | -0.56% |
| FTSE 100 | 10,600.53 | 2.95 | -0.03% |
| HKSE | 25,893.54 | 141.14 | 0.55% |
| NASDAQ | 22,902.89 | 80.48 | 0.35% |
| Nikkei 225 | 56,924.11 | 1,028.79 | 1.84% |
| NZX 50 Index | 13,181.44 | 92.37 | -0.70% |
| S&P 500 | 6,816.89 | 7.77 | -0.11% |
| S&P/ASX 200 | 8,960.60 | 36.20 | 0.41% |
| SSE Composite Index | 3,986.22 | 20.05 | 0.51% |